MANAGEMENT OF CHRONIC FATIGUE SYNDROME

Posted by Alex

Nonpharmacologic Management

Orthoses often prescribed for osteoporotic patients.Management of the patient with CFS requires more than pharmacotherapy. First, the clinician must make a personal judgment as to whether patients are accurately relating their symptoms -both those that they admit to and those that they deny. CFS is an illness defined only by symptoms. Thus, an occasional patient seeking secondary gain may fabricate a “perfect story” for CFS. Somewhat more commonly, patients who have been told that they are suffering from major depression and who find that diagnosis to be stigmatizing read about CFS in the media and come to believe that it explains their fatigue. So, the first task of the clinician is to make an admittedly arbitrary judgment as to the veracity of the symptoms reported. In my experience, with CFS and other illnesses, it is generally wisest to believe what the patient tells you.

Read the rest of this entry »

Chronic Fatigue Syndrome

Posted by Alex

Chronic Fatigue SyndromeChronic fatigue syndrome (CFS) is characterized by at least 6 months of exceptional fatigue, with several associated chronic symptoms. Chronic diseases that would exclude the diagnosis of CFS include untreated hypothyroidism, sleep apnea, chronic active hepatitis, any psychotic disorder, dementia, anorexia nervosa or bulimia nervosa, recent substance abuse, and severe obesity. Bipolar affective disorder excludes a diagnosis of CFS, but nonpsychotic unipolar major depression or anxiety disorders do not. As so defined, patients with CFS represent a small fraction (1 to 3%) of all patients seeking medical care for the complaint of chronic fatigue.

Patients with CFS may be of any age, of either sex, and from all walks of life; the typical patient is a 35-year-old white woman. The onset is often sudden, frequently after an acute “viral” syndrome. In unusual cases, CFS follows in the wake not of a nondescript “flulike” illness but of a well-defined acute infectious illness, including acute infectious mononucleosis and Lyme disease (despite adequate antibacterial therapy and the resolution of Lyme disease-specific symptoms).

Read the rest of this entry »

Polyarteritis Nodosa

Posted by Alex

Polyarteritis NodosaDefinition

Classic polyarteritis nodosa (PAN) is a multisystem, necrotizing vasculitis of small and medium-sized muscular arteries in which involvement of the renal and visceral arteries is characteristic. PAN does not involve pulmonary arteries, although bronchial vessels may be involved; granulomas, significant eosinophilia, and an allergic diathesis are not part of the classic syndrome. The term microscopic polyangiitis (microscopic polyarteritis) discribes the necrotizing vasculitis with few or no immune complexes (pauci-immune) affecting small vessels (capillaries, venules, or arterioles). Since necrotizing arteritis involving small and medium-sized arteries may also be present, it shares features with classic PAN except that glomerulonephritis is very common in microscopic polyangiitis, and pulmonary capillaritis often occurs.

Incidence And Prevalence

Pan is an uncommon disorder. The mean age at onset in reports of PAN is 48 years, and the male-to-female ratio is 1.6:1.

Pathophysiology And Pathogenesis

The vascular lesion in classic PAN is a necrotizing inflammation of small and medium-sized muscular arteries. The lesions are segmental and tend to involve bifurcations and branchings of arteries. They may spread circumferentially to involve adjacent veins. However, involvement of venules is not seen in classic PAN and, if present, suggests microscopic polyangiitis or the polyangiitis overlap syndrome (see below). In the acute stages of disease, polymorphonuclear neutrophils infiltrate all layers of the vessel wall and perivascular areas, which results in intimal proliferation and degeneration of the vessel wall. Mononuclear cells infiltrate the area as the lesions progress to the subacute and chronic stages. Fibrinoid necrosis of the vessels ensues with compromise of the lumen, thrombosis, infarction of the tissues supplied by the involved vessel, and, in some cases, hemorrhage. As the lesions heal, there is collagen deposition, which may lead to further occlusion of the vessel lumen. Aneurysmal dilatations up to 1 cm in size along the involved arteries are characteristic of classic PAN. Granulomas and substantial eosinophilia with eosinophilic tissue infiltrations are not characteristically found and suggest allergic angiitis and granulomatosis (see below). online canadian pharmacy

Read the rest of this entry »

Giant Cell Arteritis (Temporal Arteritis) and Polymyalgia Rheumatica

Posted by Alex

Temporal arteritis Classification & external resourcesDefinition

Giant cell arteritis (also called temporal arteritis) is an inflammation of medium - and large-sized arteries. The disorder most frequently involves one or more branches of the carotid artery, particularly the temporal artery. The disorder is a systemic disease which can involve arteries in multiple locations.

Incidence And Prevalence

Giant cell arteritis has a high incidence in Scandanavia and in regions of the United States with large Scandanavian populations, compared to a lower incidence in southern Europe. The annual incidence rates in individuals 50 years of age and older range from 0.49 to 23.3 per 100,000 population. It occurs almost exclusively in individuals older than 55 years; however, well-documented cases have occurred in patients 40 years old or younger. It is more common in women than in men and is rare in blacks. Familial aggregation has been reported, as has an association with HLA-DR4. In addition, genetic linkage studies have demonstrated an association of giant cell arteritis with alleles at the HLA-DRB1 locus, particularly HLA-DRB1*04 variants. The disease is closely associated with polymyalgia rheumatica, which is more common than giant cell arteritis. In Olmsted County, Minnesota, the annual incidence of polymyalgia rheumatica in individuals 50 years of age and older is 52.5 per 100,000 population. Read the rest of this entry »

New Treatments for Bursitis

Posted by Alex

BursitisWhen inflammation of a bursa is superficial, such as of the shoulder, knee, elbow, or Achilles tendon, the diagnosis of bursitis is easily accomplished. Deep bursae, such as those around the hip joint and the ischial tuberosity, do not present with obvious swelling; a diagnosis must be inferred from local tenderness and exacerbation of pain by activation of the associated muscles. In difficult cases, the temporary elimination of pain after the local instillation of an anesthetic is a useful diagnostic tool. Bursitis seldom shows up on plain radiographs, and expensive imaging studies are not routinely advocated. If possible, one should aspirate the bursa because the finding of synovial fluid helps confirm the diagnosis of bursitis. If the fluid is not clear (as is the case in most instances of “irritated” bursitis), it should be sent for culture and examined for the presence of crystals. Read the rest of this entry »

Henoch-Schönlein Purpura

Posted by Alex

Henoch-Schönlein purpura - Wikipedia, the free encyclopedia

Henoch-Schönlein purpura, also referred to as anaphylactoid purpura is a systemic vasculitis syndrome characterized by palpable purpura (usually distributed over the buttocks and lower extremities), arthralgias, gastrointestinal signs and symptoms, and glomerulonephritis. It is a small vessel vasculitis.

Incidence And Prevalence

Henoch-Schönlein purpura is usually seen in children, age from 4 to 7 years; however, the disease may also be seen in infants and adults. It is not a rare disease, accounting for approximately 5 and 24 admissions per year at one pediatric hospital. The male to female ratio is 1.5:1. A seasonal variation with a peak incidence in spring has been noted. Online Canadian Pharmacy shop

Pathophysiology And Pathogenesis

The presumptive pathogenic mechanism for Henoch-Schönlein purpura is immune-complex deposition. A number of inciting antigens have been suggested including upper respiratory tract infections, various drugs, foods, insect bites, and immunizations. IgA is the antibody class most often seen in the immune complexes and has been demonstrated in the renal biopsies of these patients. Read the rest of this entry »

Huntington’s Disease

Posted by Alex

George Huntington's 1872 paper described the disorder.Huntington’s disease is a movement disorder characterized by chorea and dementia. It is inherited in an autosomal dominant manner and occurs throughout the world, in all ethnic groups, with a prevalence rate of about 5 per 100,000. The gene responsible for the disease has been located on the short arm of chromosome No. 4. At 4p16.3 there is an expanded and unstable CAG trinucleotide repeat. Symptoms do not usually develop until after 30 years of age, by which time the patient has usually had children, and so the disease continues from one generation to the next. The cause of Huntington’s disease is unknown. Online Trusted Pharmacy

Clinical Findings

Clinical onset is usually between 30 and 50 years of age. The disease is progressive and usually leads to a fatal outcome within 15–20 years. The initial symptoms may consist of either abnormal movements or intellectual changes, but ultimately both occur. The earliest mental changes are often behavioral, with irritability, moodiness, antisocial behavior, or a psychiatric disturbance, but a more obvious dementia subsequently develops. The dyskinesia may initially be no more than an apparent fidgetiness or restlessness, but eventually choreiform movements and some dystonic posturing occur. Progressive rigidity and akinesia (rather than chorea) sometimes occur in association with dementia, especially in cases with childhood onset. CT scanning usually demonstrates cerebral atrophy and atrophy of the caudate nucleus in established cases. MRI and positron emission tomography (PET) have shown reduced glucose utilization in an anatomically normal caudate nucleus. Buy Cheap Antibiotics pills

Chorea developing with no family history of choreoathetosis should not be attributed to Huntington’s disease, at least not until other causes of chorea have been excluded clinically and by appropriate laboratory studies. In younger patients, self-limiting Sydenham’s chorea develops after group A streptococcal infections on rare occasions. If a patient presents solely with progressive intellectual failure, it may not be possible to distinguish Huntington’s disease from other causes of dementia unless there is a characteristic family history or a dyskinesia develops. Canadian Prescriptions Drugs Read the rest of this entry »

About

    So Many Advances in Medicine, So Many Yet to Come